Latest Funding News

Anagenics Limited reports a marked reduction in cash outflows and operating costs following a strategic restructuring, with full benefits expected in the latter half of FY2025. Despite divesting Face Medi, core cosmetics sales remain steady.

True North Copper Limited reported a significant cash outflow in the December 2024 quarter, driven by high operating expenses linked to voluntary administration and exploration activities. Despite ending the quarter with $19.12 million in cash, the company’s negative operating cash flow signals ongoing financial pressure.

Inventis Limited reported robust Q2 progress with over $5.7 million in confirmed orders and a $2.5 million capital raise underway in the US, signaling strong momentum in its technology-driven growth strategy.

Manhattan Corporation has secured a pivotal Farm-In Agreement with Novo Resources for its Tibooburra Gold Project and gained surface access to progress drilling at its Chebogue Lithium Project in Canada, underpinning its exploration ambitions.

Alvo Minerals reports a 7.2Mt copper-equivalent resource at Palma and promising rare earth element drill results at Ipora, while launching a contracting division to offset costs.

A1 Investments & Resources Ltd reported a $36,000 net cash outflow for the September quarter, maintaining a slim cash balance of $2,000. The company is actively pursuing acquisitions and plans to raise $300,000 through convertible notes, pending shareholder approval.

NOVONIX has advanced its position in the battery materials sector with a conditional US$754 million loan commitment from the U.S. Department of Energy and binding offtake agreements with automotive giants Stellantis and PowerCo. These milestones underpin its expansion plans for synthetic graphite production in North America.

Arcadia Minerals reports ongoing joint venture discussions across its Namibian projects and initiates a competitive bidding process for Swanson Tantalum Mine construction financing following a funding agreement termination.

Clarity Pharmaceuticals reports robust progress in its SECURE trial and secures FDA Fast Track Designation for its diagnostic agent 64Cu-SAR-bisPSMA, underpinning its growth and innovation in prostate cancer treatment.

8common Limited reports a record $1.2 million in SaaS revenue for Q2 FY25, driven by a 12% increase in users and strong government contract activity. Despite tight cash balances, the company remains funded through a chairman-backed facility.

Ark Mines Ltd reported a significant cash outflow in its December 2024 quarter, prompting plans for a capital raising to support ongoing exploration activities.

First Au Limited updates on its Victorian and Western Australian gold exploration projects, announces key board changes, and completes a $325,000 capital raise to support ongoing operations.